MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ATNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Athenex (ATNX) Ownership - Who owns Athenex?

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1001 Main Street
Phone
+1 716 427-2950
Employees
280
Web
https://www.athenex.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.77M
P/E Ratio
N/A
Total Cash
31.51M
Projected Growth
N/A
Total Debt
42.36M
Revenue
102.82M
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
3.62
Total Debt/Equity
N/A
Revenue/Share
15.72 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ATNX
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Details
Industry
N/A
Address
1001 Main Street
Phone
+1 716 427-2950
Employees
280
Web
https://www.athenex.com